Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03496753
Other study ID # LEDNipple01
Secondary ID
Status Not yet recruiting
Phase N/A
First received March 28, 2018
Last updated April 5, 2018
Start date August 20, 2018
Est. completion date August 20, 2019

Study information

Verified date April 2018
Source University of Nove de Julho
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Treatment options for nipple fissures include drug therapy with antifungal and antibiotics, topical applications of lanolin, glycerin gel, creams and lotions, the milk itself, hot compresses and silicone nipple shields. Studies involving a light-emitting diode (LED) therapy have demonstrated anti-inflammatory properties, the enhancement of the wound repair process and the control of pain.


Description:

Nipple fissures are the second major cause of the discontinuation of breastfeeding, following a sensation of insufficient milk, which leads to bottle feeding. Poor positioning of the child in relation to the breast, an inadequate frequency or duration of breastfeeding and improper suckling are the main causes of nipple fissure. Discontinuing breastfeeding deprives the infant of essential nutrients and also deprives the mother of certain health benefits. Treatment options for nipple fissures include drug therapy with antifungal and antibiotics, topical applications of lanolin, glycerin gel, creams and lotions, the milk itself, hot compresses and silicone nipple shields. Studies involving a light-emitting diode (LED) therapy have demonstrated anti-inflammatory properties, the enhancement of the wound repair process and the control of pain. As it does not cause discomfort, is relatively inexpensive and may impede the discontinuation of breastfeeding, phototherapy could be a viable option for the treatment of nipple fissures.

The aim of this study is to evaluate LED therapy in treatment of nipple fissures


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date August 20, 2019
Est. primary completion date September 20, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Nursing mothers aged 18 years or older

2. Diagnosis of nipple fissure and nipple pain with a minimum score of 1 on the Store and Champion scales

3. Having given birth to a healthy, full-term child

4. Performing exclusive breastfeeding

5. Newborn with no oral, palatal or maxillofacial abnormalities

6. Newborn weighing between 2500 and 4000 grams

Exclusion Criteria:

1. History of psychological disorder

2. Presence of mastitis

3. Bacterial or fungal infection in breasts

4. Use of breast pump or plastic nipple

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Led Therapy
The following will be the phototherapeutic parameters: total spot area: 1.44 cm²; continuous emission mode; output power: 10 mW; infrared wavelength (880 to 904 nm); fluence: 4 J/cm²; and application time: 10 minutes/session. Sessions will be held three times a week on alternating days for six consecutive weeks, totaling 18 sessions.

Locations

Country Name City State
Brazil Mandaqui Hospital São Paulo Sao Paulo

Sponsors (1)

Lead Sponsor Collaborator
University of Nove de Julho

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Nipple fissure Nipple fissure will be evaluate with digital calipers - Black Bull Scale 1 week
See also
  Status Clinical Trial Phase
Completed NCT03592121 - Study to Investigate the Effect of AB-101 in Breast Cancer Survivors Early Phase 1